Finance News – Trpv3 Inhibitor

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Ceo Tariffs Cryptocurrency Crypto Assets Stocks Investors Stock Shares Stock Market Ethereum Markets Price Xrp Investment Blockchain Sec Stablecoin Eth Etf Trade Earnings Revenue Index Solana Bse China Coinbase Ipo Token Wall Street Nasdaq Trade War Inflation Usd Interest Rates Economy Profit Sensex Digital Assets Tesla Sp 500 Gold Nse Nvidia Bse Sensex Binance Federal Reserve Bank Of England Data Center Operating Profit Djt Courts Self Regulatory Organization Nebious Group Scotland Gas Networks Runway Overleveraged Longs

Filter by:

Trpv3 Inhibitor × Past month ×

Business Insider Markets • Jun 03, 2025

Kamari Pharma Announces Closing of $23 Million Financing to Advance its First-In-Class Oral TRPV3 In...

Kamari Pharma secured $23 million in funding led by BRM Group and Pontifax to support the clinical development of its novel oral TRPV3 inhibitor targeting rare genetic skin conditi...

Read Full Article →